1yc8

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1yc8" size="450" color="white" frame="true" align="right" spinBox="true" caption="1yc8, resolution 2.7&Aring;" /> '''cAbAn33- Y37V/E44G/R...)
Line 1: Line 1:
-
[[Image:1yc8.gif|left|200px]]<br />
+
[[Image:1yc8.gif|left|200px]]<br /><applet load="1yc8" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1yc8" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1yc8, resolution 2.7&Aring;" />
caption="1yc8, resolution 2.7&Aring;" />
'''cAbAn33- Y37V/E44G/R45L triple mutant'''<br />
'''cAbAn33- Y37V/E44G/R45L triple mutant'''<br />
==Overview==
==Overview==
-
Heavy chain only antibodies of camelids bind their antigens with a single, domain, the VHH, which acquired adaptations relative to classical VHs to, function in the absence of a VL partner. Additional CDR loop, conformations, outside the canonical loop structures of VHs, broaden the, repertoire of the antigen-binding site. The combined effects of part of, the CDR3 that folds over the "former" VL binding site and framework-2, mutations to more hydrophilic amino acids, enhance the solubility of VHH, domains and prevent VL pairing. cAbAn33, a VHH domain specific for the, carbohydrate moiety of the variant surface glycoprotein of trypanosomes, has a short CDR3 loop that does not cover the former VL binding site as, well as a VH-specific Trp47 instead of the VHH-specific Gly47. Resurfacing, its framework-2 region (mutations Tyr37Val, Glu44Gly and Arg45Leu) to, mimic that of a human VH restores the VL binding capacity. In solution, the humanised VHH behaves as a soluble, monomeric entity, albeit with, reduced thermodynamic stability and affinity for its antigen. Comparison, of the crystal structures of cAbAn33 and its humanised derivative reveals, steric hindrance exerted by VHH-specific residues Tyr37 and Arg45 that, prevent the VL domain pairing, whereas Glu44 and Arg45 are key elements to, avoid insolubility of the domain.
+
Heavy chain only antibodies of camelids bind their antigens with a single domain, the VHH, which acquired adaptations relative to classical VHs to function in the absence of a VL partner. Additional CDR loop conformations, outside the canonical loop structures of VHs, broaden the repertoire of the antigen-binding site. The combined effects of part of the CDR3 that folds over the "former" VL binding site and framework-2 mutations to more hydrophilic amino acids, enhance the solubility of VHH domains and prevent VL pairing. cAbAn33, a VHH domain specific for the carbohydrate moiety of the variant surface glycoprotein of trypanosomes, has a short CDR3 loop that does not cover the former VL binding site as well as a VH-specific Trp47 instead of the VHH-specific Gly47. Resurfacing its framework-2 region (mutations Tyr37Val, Glu44Gly and Arg45Leu) to mimic that of a human VH restores the VL binding capacity. In solution, the humanised VHH behaves as a soluble, monomeric entity, albeit with reduced thermodynamic stability and affinity for its antigen. Comparison of the crystal structures of cAbAn33 and its humanised derivative reveals steric hindrance exerted by VHH-specific residues Tyr37 and Arg45 that prevent the VL domain pairing, whereas Glu44 and Arg45 are key elements to avoid insolubility of the domain.
==About this Structure==
==About this Structure==
-
1YC8 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Camelus_dromedarius Camelus dromedarius]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1YC8 OCA].
+
1YC8 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Camelus_dromedarius Camelus dromedarius]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YC8 OCA].
==Reference==
==Reference==
Line 24: Line 23:
[[Category: camel antibody]]
[[Category: camel antibody]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Sun Nov 18 09:45:05 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:03:49 2008''

Revision as of 14:03, 21 February 2008


1yc8, resolution 2.7Å

Drag the structure with the mouse to rotate

cAbAn33- Y37V/E44G/R45L triple mutant

Overview

Heavy chain only antibodies of camelids bind their antigens with a single domain, the VHH, which acquired adaptations relative to classical VHs to function in the absence of a VL partner. Additional CDR loop conformations, outside the canonical loop structures of VHs, broaden the repertoire of the antigen-binding site. The combined effects of part of the CDR3 that folds over the "former" VL binding site and framework-2 mutations to more hydrophilic amino acids, enhance the solubility of VHH domains and prevent VL pairing. cAbAn33, a VHH domain specific for the carbohydrate moiety of the variant surface glycoprotein of trypanosomes, has a short CDR3 loop that does not cover the former VL binding site as well as a VH-specific Trp47 instead of the VHH-specific Gly47. Resurfacing its framework-2 region (mutations Tyr37Val, Glu44Gly and Arg45Leu) to mimic that of a human VH restores the VL binding capacity. In solution, the humanised VHH behaves as a soluble, monomeric entity, albeit with reduced thermodynamic stability and affinity for its antigen. Comparison of the crystal structures of cAbAn33 and its humanised derivative reveals steric hindrance exerted by VHH-specific residues Tyr37 and Arg45 that prevent the VL domain pairing, whereas Glu44 and Arg45 are key elements to avoid insolubility of the domain.

About this Structure

1YC8 is a Single protein structure of sequence from Camelus dromedarius. Full crystallographic information is available from OCA.

Reference

Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH., Conrath K, Vincke C, Stijlemans B, Schymkowitz J, Decanniere K, Wyns L, Muyldermans S, Loris R, J Mol Biol. 2005 Jul 1;350(1):112-25. PMID:15913651

Page seeded by OCA on Thu Feb 21 16:03:49 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools